Clinical Trial Update: Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of tremelimumab and durvalumab in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Durvalumab (durvalumab)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Hepatocellular Carcinoma, Cirrhosis, Liver | Phase 2 | Status: RECRUITING